A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0843
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors ; day:7 ; month:8 ; year:2018 ; pages:1-10
Cancer chemotherapy and pharmacology ; (7.8.2018), 1-10
- Creator
-
O’Brien, Mary E. R.
- Contributor
-
Sarker, Debashis
Bhosle, Jaishree
Thillai, Kiruthikah
Yap, Timothy A.
Uttenreuther-Fischer, Martina
Pemberton, Karine
Jin, Xidong
Wiebe, Sabrina
Bono, Johann de
Spicer, James
SpringerLink (Online service)
- DOI
-
10.1007/s00280-018-3661-1
- URN
-
urn:nbn:de:101:1-2018100720115378333861
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- O’Brien, Mary E. R.
- Sarker, Debashis
- Bhosle, Jaishree
- Thillai, Kiruthikah
- Yap, Timothy A.
- Uttenreuther-Fischer, Martina
- Pemberton, Karine
- Jin, Xidong
- Wiebe, Sabrina
- Bono, Johann de
- Spicer, James
- SpringerLink (Online service)
Other Objects (12)
Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy
Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report
Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis
Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus nab -Paclitaxel and Maintenance Monotherapy with nab -Paclitaxel: Two Case Reports
Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study
Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer
Paclitaxel und Paclitaxel-Carboplatin beim fortgeschrittenen nichtkleinzelligen Bronchialkarzinom : Auswertung klinischer Phase-II-Studien
Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Nab-Paclitaxel + Carboplatin bei fortgeschrittenem NSCLC : Fallsamlung von 7 Kasuistiken
Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers
PD-1/PD-L1 inhibitors plus carboplatin and paclitaxel compared with carboplatin and paclitaxel in primary advanced or recurrent endometrial cancer: a systematic review and meta-analysis of randomized clinical trials
Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy
Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report
Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis
Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus nab -Paclitaxel and Maintenance Monotherapy with nab -Paclitaxel: Two Case Reports
Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study
Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer
Paclitaxel und Paclitaxel-Carboplatin beim fortgeschrittenen nichtkleinzelligen Bronchialkarzinom : Auswertung klinischer Phase-II-Studien
Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Nab-Paclitaxel + Carboplatin bei fortgeschrittenem NSCLC : Fallsamlung von 7 Kasuistiken
Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers
PD-1/PD-L1 inhibitors plus carboplatin and paclitaxel compared with carboplatin and paclitaxel in primary advanced or recurrent endometrial cancer: a systematic review and meta-analysis of randomized clinical trials
Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy
Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report
Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis
Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus nab -Paclitaxel and Maintenance Monotherapy with nab -Paclitaxel: Two Case Reports
Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study
Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer
Paclitaxel und Paclitaxel-Carboplatin beim fortgeschrittenen nichtkleinzelligen Bronchialkarzinom : Auswertung klinischer Phase-II-Studien
Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Nab-Paclitaxel + Carboplatin bei fortgeschrittenem NSCLC : Fallsamlung von 7 Kasuistiken
Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers